Researchers have assessed the impact antibiotic therapy on short (hospital) and long-term (6 months) outcomes of ICU patients with severe community-acquired pneumonia. Community-acquired pneumonia (CAP) remains one of the leading causes of hospital admission, with 5% to 15% of cases being admitted to an ICU, largely due to complications like shock and respiratory failure. Severe CAP has a mortality rate of about 30%. Yet, despite several guidelines and studies supporting the use of antibiotic therapy for the management of severe CAP, doubts remain regarding the optimal treatment approach for patients with this infection.

Read More